Host cells for production of isoprenoid compounds
View Patent ↗Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
1. A transformed host cell that synthesizes an isoprenoid or an isoprenoid precursor via a mevalonate pathway,
wherein the transformed host cell is a prokaryote that does not normally synthesize isopentenyl pyrophosphate (IPP) through the mevalonate pathway, wherein the transformed host cell comprises one or more nucleic acids heterologous to the host cell, wherein the one or more heterologous nucleic acids comprises nucleotide sequences that encode mevalonate pathway enzymes comprising:
(a) an enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA as the first step in the synthesis of the isoprenoid or isoprenoid precursor;
(b) an enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form 3 hydroxy 3 methylglutaryl CoA (HMG-CoA);
(c) an enzyme that converts HMG-CoA to mevalonate;
(d) an enzyme that phosphorylates mevalonate to mevalonate 5-phosphate;
(e) an enzyme that converts mevalonate 5-phosphate to mevalonate 5-pyrophosphate; and
(f) an enzyme that converts mevalonate 5-pyrophosphate to isopentenyl pyrophosphate,
wherein culturing of said transformed host cell in a suitable medium provides for synthesis of the isoprenoid or isoprenoid precursor in a recoverable amount of at least about 5 mg/L.
2. The transformed host cell of claim 1 , wherein the one or more heterologous nucleic acids is integrated into the chromosome of the host cell.
3. The transformed host cell of claim 1 , wherein the one or more heterologous nucleic acids is contained in at least one extrachromosomal expression vector.
4. The transformed host cell of claim 1 , wherein the one or more heterologous nucleic acids is present in a single expression vector.
5. The transformed host cell of claim 1 , wherein said nucleotide sequences are present in two or more operons.
6. The transformed host cell of claim 1 , wherein the transformed host cell overproduces the isoprenoid or isoprenoid precursor by at least about 5 fold as compared to a control host cell that is not transformed with the one or more heterologous nucleic acids.
7. The transformed host cell of claim 1 , wherein the transformed host cell further comprises a heterologous nucleic acid comprising a nucleotide sequence coding isopentenyl pyrophosphate isomerase.
8. The transformed host cell of claim 7 , wherein the isoprenoid precursor is IPP, and wherein the IPP is further modified enzymatically by the action of the isopentenyl pyrophosphate isomerase to generate dimethylallyl pyrophosphate (DMAPP).
9. The transformed host cell of claim 8 , wherein the transformed host cell further comprises a heterologous nucleic acid comprising a nucleotide sequence encoding one or more polyprenyl pyrophosphate synthases.
10. The transformed host cell of claim 9 , wherein the DMAPP is further modified enzymatically with the one or more polyprenyl pyrophosphate synthases to provide an isoprenoid.
11. The transformed host cell of claim 10 , wherein the isoprenoid is a monoterpene, a sesquiterpene, a diterpene, a triterpene, a tetraterpene, or a steroid.
12. The transformed host cell of claim 1 , wherein the transformed host cell is of a genus selected from Escherichia, Enterobacter, Azotobacter, Erwinia, Bacillus, Pseudomonas, Klebsiella, Proteus, Salmonella, Serratia, Shigella, Rhizobia, Vitreoscilla, and Paracoccus.
13. The transformed host cell of claim 1 , wherein said transformed host cell also synthesizes IPP via a deoxyxylulose-5 phosphate (DXP) pathway.
14. The transformed host cell of claim 1 , wherein said transformed host cell comprises an inactivated deoxyxylulose-5 phosphate (DXP) pathway.
15. A transformed Escherichia coli host cell that synthesizes an isoprenoid or an isoprenoid precursor via a mevalonate pathway,
wherein the transformed host cell is a prokaryote that does not normally synthesize isopentenyl pyrophosphate (IPP) through the mevalonate pathway, wherein the transformed host cell comprises one or more nucleic acids heterologous to the host cell, wherein the one or more heterologous nucleic acids comprises nucleotide sequences that encode mevalonate pathway enzymes comprising:
(a) an enzyme that condenses two molecules of acetyl-CoA to acetoacetyl-CoA as the first step in the synthesis of the isoprenoid or isoprenoid precursor;
(b) an enzyme that condenses acetoacetyl-CoA with acetyl-CoA to form 3 hydroxy 3 methylglutaryl CoA (HMG-CoA);
(c) an enzyme that converts HMG-CoA to mevalonate;
(d) an enzyme that phosphorylates mevalonate to mevalonate 5-phosphate;
(e) an enzyme that converts mevalonate 5-phosphate to mevalonate 5-pyrophosphate; and
(f) an enzyme that converts mevalonate 5-pyrophosphate to isopentenyl pyrophosphate,
wherein culturing of said transformed host cell in a suitable medium provides for synthesis of the isoprenoid or isoprenoid precursor in a recoverable amount of at least about 5 mg/L.
16. The transformed host cell of claim 15 , wherein said transformed host cell comprises an inactivated deoxyxylulose-5 phosphate (DXP) pathway.
17. The transformed host cell of claim 15 , wherein the transformed host cell further comprises a heterologous nucleic acid comprising a nucleotide sequence coding isopentenyl pyrophosphate isomerase.
18. The transformed host cell of claim 17 , wherein the isoprenoid precursor is IPP, and wherein the IPP is further modified enzymatically by the action of the isopentenyl pyrophosphate isomerase to generate dimethylallyl pyrophosphate (DMAPP).
19. The transformed host cell of claim 18 , wherein the transformed host cell further comprises a heterologous nucleic acid comprising a nucleotide sequence encoding one or more polyprenyl pyrophosphate synthases.
20. The transformed host cell of claim 19 , wherein the DMAPP is further modified enzymatically with the one or more polyprenyl pyrophosphate synthases to provide an isoprenoid.
21. The transformed host cell of claim 15 , wherein the isoprenoid is a monoterpene.
22. The transformed host cell of claim 21 , wherein the monoterpene is selected from limonene, citranellol, and geraniol.
23. The transformed host cell of claim 15 , wherein the isoprenoid is a sesquiterpene.
24. The transformed host cell of claim 23 , wherein the sesquiterpene is selected from periplanone B, artemisinin, ginkgolide B, forskolin, and farnesol.
25. The transformed host cell of claim 15 , wherein the isoprenoid is a diterpene.
26. The transformed host cell of claim 15 , wherein the diterpene is selected from casbene and paclitaxel.
27. The transformed host cell of claim 15 , wherein the isoprenoid is a triterpene.
28. The transformed host cell of claim 15 , wherein the isoprenoid is a tetraterpene.
29. The transformed host cell of claim 15 , wherein the isoprenoid is a steroid.
30. The transformed host cell of claim 15 , wherein the isoprenoid is lycopene.
31. The transformed host cell of claim 15 , wherein the isoprenoid is casbene.
32. The transformed host cell of claim 15 , wherein the isoprenoid is amorphadiene.